Centagenetix uses genomics approaches to study human longevity.

History:

Centagenetix merged with Elixir Pharmaceuticals in 2003.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: private

Employees:

Regions:
Northeast

Research Focus:
Development Genomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: